The broadband expansion, especially in rural areas, will allow more people to access telehealth. But a panel at MedCity INVEST in Chicago said that's not enough to tackle the social determinants of health.
By Michael Schroeder Wednesday, March 30, 2022 9:00 PM
The broadband expansion, especially in rural areas, will allow more people to access telehealth. But a panel at MedCity INVEST in Chicago said that's not enough to tackle the social determinants of health.
By Frank Vinluan Wednesday, March 30, 2022 12:26 PM
Neuron23 is developing drugs that treat neurological conditions by penetrating the blood-brain barrier to reach disease targets in the central nervous system. The biotech's lead program is a Parkinson's disease drug candidate with features that could distinguish it from rival compounds that are aiming for the same target.
By Dr. Sara Pastoor Wednesday, March 30, 2022 9:00 AM
Primary care has demonstrated remarkable resilience in spite of the intense pressures of the pandemic, and there is critical work to do to help our nation recover from the wide-ranging consequences of Covid-19.
In this episode of the MedCity Pivot Podcast, Jonathan Bush talks about his latest venture - Zus Health - through which he wants to help digital health companies share data to create a universal patient off of which new products can be created to serve payers, providers and others with the ultimate goal of improving patient outcomes.
No comments